Research ArticleCancer

Improved cancer immunotherapy by a CD25-mimobody conferring selectivity to human interleukin-2

See allHide authors and affiliations

Science Translational Medicine  30 Nov 2016:
Vol. 8, Issue 367, pp. 367ra166
DOI: 10.1126/scitranslmed.aag3187

Log in to view Figures & Data

Log in through your institution

Log in through your institution